1,908
Views
5
CrossRef citations to date
0
Altmetric
Oncology

Prognostic and clinicopathological significance of Systemic Immune-Inflammation Index in cancer patients receiving immune checkpoint inhibitors: a meta-analysis

&
Pages 808-819 | Received 25 Oct 2022, Accepted 13 Feb 2023, Published online: 09 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ke-Xin Sun, Ru-Qin Xu, Huan Rong, Hua-Yang Pang & Ting-Xiu Xiang. (2023) Prognostic significance of the Gustave Roussy immune (GRIm) score in cancer patients: a meta-analysis. Annals of Medicine 55:2.
Read now

Articles from other publishers (4)

Zehao Zhao, Xiaoming Zhang, Tienan Sun, Xin Huang, Meishi Ma, Shiwei Yang & Yujie Zhou. (2023) Prognostic value of systemic immune‐inflammation index in CAD patients: Systematic review and meta‐analyses. European Journal of Clinical Investigation.
Crossref
Chunxun Liu, Haoran Zhao, Rujia Zhang, Zuoming Guo, Peng Wang & Zhaowei Qu. (2023) Prognostic value of nutritional and inflammatory markers in patients with hepatocellular carcinoma who receive immune checkpoint inhibitors. Oncology Letters 26:4.
Crossref
Arduino A. Mangoni & Angelo Zinellu. (2023) Systemic inflammation index, disease severity, and mortality in patients with COVID-19: a systematic review and meta-analysis. Frontiers in Immunology 14.
Crossref
Zaijing Fan & Lihong Shou. (2023) Prognostic and clinicopathological impacts of systemic immune-inflammation index on patients with diffuse large B-cell lymphoma: a meta-analysis. Therapeutic Advances in Hematology 14.
Crossref